Core Laboratories (CLB) Reports In-Line Q2 EPS, Offers Q4 Guidance
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Price: $10.83 -1.01%
EPS Growth %: +45.5%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +45.5%
Financial Fact:
General and Administrative Expense, Excluding Depreciation: 8.41M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Core Laboratories (NYSE: CLB) reported Q2 EPS of $0.35, in-line with the analyst estimate of $0.35. Revenue for the quarter came in at $148.1 million versus the consensus estimate of $146.4 million.
GUIDANCE:
Core Laboratories sees Q3 2016 EPS of $0.39-$0.41, versus the consensus of $0.41. Core Laboratories sees Q3 2016 revenue of $148-151 million, versus the consensus of $149.4 million.
For earnings history and earnings-related data on Core Laboratories (CLB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c
- Amrize Ltd (AMRZ) PT Lowered to $42 at UBS on Lower Earnings Estimates
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
